Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Cardinal Health

Why Gen Z is flagging higher levels of bullying at work

Reports of bullying in the workplace have increased thanks, in part, to remote work.

Fortune

How Cardinal Health creates benefits for its 5-generation workforce

Health care company Cardinal Health has customized benefits for all five generations in its workforce.

Fortune

2 Health Care Stocks You Can't Go Wrong with Buying Right Now

Government funding for the healthcare industry is increasing significantly. Additionally, progressions in hospitals’ digital architecture and a surge in telemedicine brought on by the convergence of the COVID-19 pandemic and 5G networks are further boosting the industry’s growth. Hence, investing in fundamentally strong healthcare stocks AbbVie (ABBV) and Cardinal Health…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Stocks to Buy That Could Make You a Millionaire in the Long Term

Yesterday’s retail sales report showed that consumers pulled back on spending last month, raising fears of a recession. Moreover, the Fed signaled to keep raising rates more through the following year. Given an uncertain market backdrop, investors should buy fundamentally sound and dividend-paying stocks Johnson (JNJ), Coca-Cola (KO), and Cardinal…

StockNews.com

2 Stocks You'll Be Glad You Bought in 2022

The stock market has been under immense pressure this year. However, the solid start to the earnings season is lifting investors’ optimism. And we think fundamentally sound stocks Kroger (KR) and Cardinal Health (CAH) which have been gaining despite market downturns, could be worth owning. Read more.

StockNews.com

In California's largest race bias cases, Latino workers are accused of abusing Black colleagues

Nearly every day, the onetime Ontario, California, warehouse employee said, he was stunned to hear racist slurs from Latino co-workers.

Los Angeles Times

Illinois Senate President Don Harmon, other pols keep taking money from pharma companies implicated in opioid crisis

The Oak Park Democrat continues to accept campaign money from Johnson & Johnson, 1 of 4 companies paying $26 billion to settle suits accusing them of fueling the crisis. He’s not the only Illinois official doing so.

Chicago Sun-Times

Read news from The Economist, FT, and more,
with one subscription

Recession Investing: 5 High Yield Dividend Stocks For A Downturn

As the healthcare industry absorbed enormous amounts of profits during the Covid-19 pandemic, many healthcare companies will be increasing shareholder distributions to entice investors to buy their stock.

Benzinga

WVa cities, counties reach $400M settlement with drug firms

West Virginia cities and counties have reached a $400 million tentative settlement with three major U.S. drug distributors

The Independent UK

A federal judge sides with 3 major drug distributors in a landmark opioid lawsuit

The lawsuit accused them of causing a health crisis by distributing 81 million pills over eight years in one West Virginia county ravaged by opioid addiction.

WEKU

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022

Benzinga

Idaho announces $119 million opioid crisis settlement

Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.

WEKU

Idaho announces $119 million opioid crisis settlement

Idaho officials have announced a $119 million settlement with drugmaker Johnson & Johnson and three major distributors over their role in the opioid addiction crisis

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Cardinal Health's Shares Fall as Inflation and Supply Chain Constraints Hit Q3 Earnings

Cardinal Health Inc (NYSE:CAH) has reported Q3 FY22 adjusted EPS of $1.45, down 5% Y/Y, missing the consensus of $1.52 Q2 sales increased 14% Y/Y to $44.8 billion, beating the consensus estimate of $43.16 billion. The pharmaceutical segment increased 17% to $41 billion, driven primarily by branded pharmaceutical sales growth from large…

Benzinga

Cardinal Health: Q3 Earnings Insights

Cardinal Health (NYSE:CAH) reported its Q3 earnings results on Thursday, May 5, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga

Washington, Drug Distributors Reach $518M Settlement For Opioid Claims

Washington has reached a $518 million settlement with drug distributors McKesson Corporation (NYSE:MCK), AmerisourceBergen Corp (NYSE:ABC), and Cardinal Health Inc (NYSE:CAH) to resolve opioid-related claims. Washington opted out of a $26 billion nationwide opioid settlement involving the three drug distributors and Johnson & Johnson (NYSE:JNJ). Reuters writes that it would…

The Independent UK

J&J's Janssen settles with WVa for $99M in opioid lawsuit

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

WVa trial expert: Drug makers downplayed risks in marketing

Lawyers for the state of West Virginia are concluding the first week of a trial against three major opioid makers

The Independent UK

US drug czar testifies in WVa lawsuit against opioid makers

The new White House drug czar has testified that the opioid epidemic got so bad in drug-ravaged West Virginia that the state was having trouble finding foster parents to care for children

The Independent UK

Trial begins in West Virginia lawsuit against opioid makers

Opening arguments have taken place in a West Virginia lawsuit accusing several drugmakers of misrepresenting the risks and benefits of opioids

Benzinga

This Favorable Sign Appears On Cardinal Health's Chart

If history is any guide, there may be good fortune ahead for shares of Cardinal Health (NYSE:CAH). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga

Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits

Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH

Benzinga

Expert Ratings For Cardinal Health

Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter:

Benzinga

Where Cardinal Health Stands With Analysts

Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter:

1 2 3 4

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.